David Colpman - Oct 20, 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
Director
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for David Colpman
Stock symbol
ELUT
Transactions as of
Oct 20, 2022
Transactions value $
$0
Form type
4
Date filed
10/24/2022, 04:54 PM
Next filing
Dec 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Stock Option (Right to Buy) Award $0 +28.5K $0.00 28.5K Oct 20, 2022 Class A Common Stock 28.5K $7.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests annually in three equal installments of one-third each, on each of the first three anniversaries of the grant date, such that the option shall be fully vested and exercisable on October 20, 2025.